Insider Buying: Creo Medical Group PLC (LON:CREO) Insider Purchases £895.28 in Stock

Creo Medical Group PLC (LON:CREO) insider Richard John Rees purchased 4,712 shares of the stock in a transaction that occurred on Thursday, January 16th. The stock was purchased at an average cost of GBX 19 ($0.23) per share, with a total value of £895.28 ($1,105.83).

Richard John Rees also recently made the following trade(s):

• On Thursday, October 24th, Richard John Rees acquired 98,000 shares of Creo Medical Group stock. The shares were bought at an average cost of GBX 20 ($0.25) per share, for a total transaction of £19,600 ($24,209.49).

Creo Medical Group Price Performance

Shares of Creo Medical Group stock opened at GBX 18 ($0.22) on Friday. The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96. The firm has a fifty day simple moving average of GBX 17.56 and a 200-day simple moving average of GBX 23.36. The stock has a market capitalization of £65.12 million, a price-to-earnings ratio of -300.00 and a beta of 0.86. Creo Medical Group PLC has a 1-year low of GBX 12 ($0.15) and a 1-year high of GBX 43 ($0.53).

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.